Lactose (India)

Lactose_(India)29 Apr 2024

Pharmaceuticals

₹

-8.40 (-4.99%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Lactose (India)

Lactose (India)

Pharmaceuticals

Lactose_(India)29 Apr 2024

₹

-8.40 (-4.99%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Feb-2024	BC	LACTOSE (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Draft Un-audited Financial Results of t	14-Feb-2024
02-Jan-2024	BC	Sangita Maheshwari	30-Dec-2023
02-Jan-2024	BC	Shyamsundar Toshniwal	30-Dec-2023
02-Jan-2024	BC	Madhubala Toshniwal	30-Dec-2023
20-Dec-2023	BC	In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at th	20-Dec-2023

No Rights has been declared by Lactose_(India)

Book Closure

Record Date	Split Date	Purpose
14-Feb-2024	-	LACTOSE (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Draft Un-audited Financial Results of t
30-Dec-2023	-	Sangita Maheshwari
30-Dec-2023	-	Shyamsundar Toshniwal
30-Dec-2023	-	Madhubala Toshniwal
20-Dec-2023	-	In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at th

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lactose (India) Ltd ₹160.10(-8.40/-4.99%)	160.10	-8.40	212.12	284.88	40.21	5.01
Astrazeneca Pharma India Ltd ₹5,490.60(+75.20/1.39%)	5,490.60	+75.20	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.75(+2.15/1.75%)	124.75	+2.15	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,395.65(-13.75/-0.98%)	1,395.65	-13.75	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,010.00(+145.15/0.56%)	26,010.00	+145.15	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹700.90(+20.05/2.94%)	700.90	+20.05	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	32.60	24.43	27.47	25.99	17.02	13.17
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	32.60	24.43	27.47	25.99	17.02	13.17
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.28	0.26	0.28	0.15	0.16	0.20
Total Income	32.88	24.68	27.75	26.14	17.17	13.37
Total Expenditure	26.87	21.03	23.70	21.90	14.28	10.81
PBIDT	6.01	3.65	4.05	4.23	2.89	2.56
Interest	1.21	1.31	1.55	1.93	1.55	1.31
PBDT	4.79	2.34	2.50	2.31	1.34	1.24
Depreciation	1.20	1.20	1.19	1.19	1.17	1.17
Tax	0.60	0.19	0.22	0.19	0.04	-0.05
Deferred Tax	0.37	0.14	0.13	0.04	-0.02	0.04
Reported Profit After Tax	2.63	0.81	0.96	0.89	0.14	0.09
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	2.63	0.81	0.96	0.89	0.14	0.09

EPS (Unit Curr.)	2.09	0.64	0.76	0.71	0.11	0.07
EPS (Adj) (Unit Curr.)	2.09	0.64	0.76	0.71	0.11	0.07
Calculated EPS (Unit Curr.)	2.09	0.64	0.76	0.71	0.11	0.07
Calculated EPS (Adj) (Unit Curr.)	2.09	0.64	0.76	0.71	0.11	0.07
Calculated EPS (Ann.) (Unit Curr.)	8.35	2.56	3.04	2.83	0.46	0.28
Calculated EPS (Adj) (Ann.) (Unit Curr.)	8.35	2.56	3.04	2.83	0.46	0.28
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	12.59	12.59	12.59	12.59	12.59	12.59
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	18.44	14.94	14.74	16.28	16.98	19.44
PBDTM(%)	14.69	9.58	9.10	8.89	7.87	9.42
PATM(%)	8.07	3.32	3.49	3.42	0.82	0.68

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	12.59	12.59	11.44	10.19	10.19	10.04
Reserves Total	27.97	26.70	23.05	24.10	24.06	21.13
Equity Share Warrants	0.00	0.00	0.60	0.00	0.00	0.59
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	40.56	39.29	35.09	34.29	34.25	31.76
Secured Loans	38.79	40.96	42.88	38.55	35.74	37.31
Unsecured Loans	0.16	0.37	3.26	0.89	0.30	0.27
Total Debt	38.95	41.33	46.14	39.44	36.04	37.58
Total Liabilities	79.51	80.62	81.23	73.73	70.29	69.34
APPLICATION OF FUNDS :
Gross Block	82.26	81.11	77.71	75.82	70.84	70.07
Less : Accumulated Depreciation	26.19	21.90	18.24	14.00	10.46	6.90
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	56.07	59.21	59.47	61.82	60.38	63.17
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	3.52	0.23	1.48	0.25
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.74	0.68	0.07	0.08	0.06
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	22.78	7.12	8.32	8.91	8.11	7.13
Sundry Debtors	12.49	11.35	6.43	6.98	6.87	5.38
Cash and Bank	0.92	2.08	2.66	1.88	0.94	2.79
Loans and Advances	1.32	2.20	2.29	2.04	1.78	1.61
Total Current Assets	37.50	22.75	19.70	19.81	17.70	16.91
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	20.52	8.00	5.05	6.81	7.52	9.00
Provisions	0.13	0.07	0.02	0.07	0.05	0.03
Total Current Liabilities	20.65	8.07	5.08	6.87	7.57	9.03
Net Current Assets	16.85	14.67	14.62	12.93	10.13	7.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	6.28	6.46	6.88	6.02	5.98	5.49
Deferred Tax Liability	6.96	7.04	7.33	7.30	7.27	6.63
Net Deferred Tax	-0.68	-0.58	-0.45	-1.28	-1.29	-1.14
Total Assets	72.24	74.05	77.83	73.78	70.79	70.21
Contingent Liabilities	6.59	3.32	3.16	0.53	0.29	0.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.92	2.16	1.65	0.69	2.68
Net Cash from Operating Activities	8.06	8.47	2.16	7.41	4.93
Net Cash Used In Investing Activities	-1.02	-0.56	-6.18	-2.88	-1.80
Net Cash Used In Financing Activities	-8.38	-8.14	4.52	-3.57	-5.12
Net Inc./Dec In Cash And Cash Equivalents	-1.34	-0.24	0.51	0.96	-1.99
Cash And Cash Equivalents At End Of The Year	0.58	1.92	2.16	1.65	0.69

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

53.65%

FII Shareholding

0.00%

DII Shareholding

0.62%

Public Shareholding

45.74%

**Promoter pledged shareholding 53.65%

About Lactose (India) Ltd

Lactose (India) Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 212.12 crores. It has reported a sales of Rs. 32.6 crores and a net profit of Rs. 2.63 crores for the quarter ended December 2018. The company management includes Atul Maheshwari, Atul Maheshwari,S M Maheshwari,Pramod Kalani,G K Sarda,Dhaval J Soni (Lactose (India) Ltd) among others.

Chairman

Atul Maheshwari

Registered office

Survey No 6,Village Poicha (Rania) Savli,Vadodara,Gujarat,391780

FAX :91-02667-840397

Background

Incorporation Year1991

Face Value₹10

Market Lot1

How to buy Lactose (India) shares on nse?

To buy Lactose (India) shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lactose (India) share price today?

The Lactose (India) shares price on nse is Rs.160.1 today.

What is the market cap of Lactose (India) shares on BSE ?

The company has a market capitalization of Rs.212.12Cr

What is the PE & PB ratio of Lactose (India) shares ?

PE is 40.21 and PB is 5.01

What is the 52 Week High and Low of Lactose (India) shares?

Lactose (India) stock price high: Rs.173.65 Lactose (India) stock price low: Rs.40.2